Recommendations on Screening for Hydroxychloroquine and Chloroquine Retinopathy. American Academy of Ophthalmology. https://www.aao.org/education/clinical-statement/revised-recommendations-on-screening-chloroquine-h. Date Accessed March 16, 2026.
Is 10-2 Testing Needed for Early VF Loss? American Academy of Ophthalmology. https://www.aao.org/eyenet/article/is-10-2-testing-needed-for-early-vf-loss. Date Accessed March 16, 2026.
Comparison of 10-2 and 24-2 Perimetry to Diagnose Glaucoma Using OCT as an Independent Reference Standard. PubMed. https://pubmed.ncbi.nlm.nih.gov/36084839/. Date Accessed March 16, 2026.
Qualitative Evaluation of the 10-2 and 24-2 Visual Field Tests for Detecting Central Visual Field Abnormalities in Glaucoma. PubMed Central. https://pmc.ncbi.nlm.nih.gov/articles/PMC8379296/. Date Accessed March 16, 2026.
Comparing Glaucoma Progression on 24-2 and 10-2 Visual Field Examinations. PLOS One. https://journals.plos.org/plosone/article?id=10.1371%2Fjournal.pone.0127233&. Date Accessed March 16, 2026.